(Q37103993)

18 August 2017

1 reference

title

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

1

Xavier Rebillard

1 reference

Emmanuel Chartier-Kastler

18 August 2017

3

object named as

Emmanuel Chartier-Kastler

1 reference

18 August 2017

Michel Soulié

2

1 reference

18 August 2017

Jean-Louis Davin

4

1 reference

18 August 2017

Jean-Pierre Mignard

5

1 reference

18 August 2017

Jean-Luc Moreau

6

1 reference

18 August 2017

Christian Coulange

7

1 reference

18 August 2017

Association Francaise d'Urologie

8

1 reference

18 August 2017

language of work or name

1 reference

4 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

101

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

1205-1213

1 reference

High-intensity focused ultrasound for treating prostate cancer.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Control of prostate cancer by transrectal HIFU in 227 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

High-intensity focused ultrasound therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Treatment of localized prostate cancer using high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

HIFU and cryoablation--non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Incontinence and erectile dysfunction following radical prostatectomy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Complications following permanent prostate brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

Erectile function outcome reporting after clinically localized prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07504.X

10.1111/J.1464-410X.2008.07504.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference